Basic Information
| LncRNA/CircRNA Name | circ_101237 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Multiple Myeloma |
| ICD-0-3 | C42.1 |
| Methods | qPCR |
| Sample | Multiple Myeloma tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | The average expressions of hsa_circRNA_101237 in the bone marrow tissues from MM patients (especially those with recurrent/refractory disease), MM cells and bortezomib-resistant MM cell lines were increased significantly (P<0.01). |
| Pubmed ID | 32256118 |
| Year | 2020 |
| Title | hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma |
External Links
| Links for circ_101237 | GenBank HGNC NONCODE |
| Links for Multiple Myeloma | OMIM COSMIC |